{"entity":{"type":"insider","cik":"0001673754","url":"/insider/0001673754","json_url":"/insider/0001673754.json","name":"TLS Beta Pte. Ltd.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2016-05-13","last":"2019-10-18","span_basis":"filed_date"},"name_variants":[{"name":"TLS Beta Pte. Ltd.","source":"filing","n_filings":3,"first_seen":"2016-05-13","last_seen":"2019-10-18"}],"transactions":[{"id":8091773,"accession":"0000899243-19-025766","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-025766","line_url":"/filing/0000899243-19-025766#line-3","is_derivative":false,"issuer_cik":"0001021944","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001021944","owner_cik":null,"owner_name":"TLS Beta Pte. Ltd.; Fullerton Management Pte Ltd; V-Sciences Investments Pte Ltd; Temasek Holdings (Private) Ltd; Temasek Life Sciences Private Ltd","owner_display_name":"TLS Beta Pte. Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","total_whole":"10,000,000","shares_owned_after":5499999.0,"shares_owned_after_display":"5,499,999","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-10-16","filed_date":"2019-10-18","scope":"insider"},{"id":6435827,"accession":"0000899243-18-009413","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-18-009413","line_url":"/filing/0000899243-18-009413#line-3","is_derivative":false,"issuer_cik":"0001021944","issuer_name":"Homology Medicines, Inc.","issuer_ticker":"FIXX","issuer_name_source":null,"issuer_url":"/issuer/0001021944","owner_cik":null,"owner_name":"Temasek Holdings (Private) Ltd; Fullerton Management Pte Ltd; TLS Beta Pte. Ltd.; Temasek Life Sciences Private Ltd; V-Sciences Investments Pte Ltd","owner_display_name":"Temasek Holdings (Private) Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":625000.0,"shares_display":"625,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","total_whole":"10,000,000","shares_owned_after":3220293.0,"shares_owned_after_display":"3,220,293","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-04-02","filed_date":"2018-04-04","scope":"insider"},{"id":2495242,"accession":"0000899243-16-019823","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-16-019823","line_url":"/filing/0000899243-16-019823#line-2","is_derivative":false,"issuer_cik":"0001021944","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001021944","owner_cik":null,"owner_name":"Temasek Life Sciences Private Ltd; Fullerton Management Pte Ltd; Temasek Holdings (Private) Ltd; TLS Beta Pte. Ltd.","owner_display_name":"Temasek Life Sciences Private Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300000.0,"shares_display":"300,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":5400000.0,"total_display":"5,400,000.00","total_whole":"5,400,000","shares_owned_after":790527.0,"shares_owned_after_display":"790,527","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-11","filed_date":"2016-05-13","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001706431","name":"Vir Biotechnology, Inc.","url":"/issuer/0001706431","role":"Ten percent owner","n_filings":1,"first_seen":"2019-10-18","last_seen":"2019-10-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001661998","name":"Homology Medicines, Inc.","url":"/issuer/0001661998","role":"Ten percent owner","n_filings":1,"first_seen":"2018-04-04","last_seen":"2018-04-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001652130","name":"Intellia Therapeutics, Inc.","url":"/issuer/0001652130","role":"Ten percent owner","n_filings":1,"first_seen":"2016-05-13","last_seen":"2016-05-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001673754","retrieved_at":"2026-08-25T23:10:55+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}